+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

WHIM Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

WHIM Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Radiation-induced Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Radiation-induced Esophagitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
From
Plantar Fasciitis - Pipeline Insight, 2025 - Product Thumbnail Image

Plantar Fasciitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Functional Dyspepsia - Pipeline Insight, 2025 - Product Thumbnail Image

Functional Dyspepsia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Proliferative Diabetic Retinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Proliferative Diabetic Retinopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Myocarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Myocarditis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Lymphedema - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphedema - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Primary Axillary Hyperhidrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Axillary Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Dense Deposit Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dense Deposit Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Drug Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Drug Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Drug-Resistant Refractory Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Drug-Resistant Refractory Epilepsy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dupuytren Contracture - Pipeline Insight, 2025 - Product Thumbnail Image

Dupuytren Contracture - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2025 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EGFR Inhibitors Induced Skin Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

EGFR Inhibitors Induced Skin Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Female Trichomoniasis Vaginalis - Pipeline Insight, 2025 - Product Thumbnail Image

Female Trichomoniasis Vaginalis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Covid-19 - Pipeline Insight, 2025 - Product Thumbnail Image

Covid-19 - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 450 Pages
  • Global
From
Obesity - Pipeline Insight, 2025 - Product Thumbnail Image

Obesity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more